Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
86.5 EUR | +0.83% | -1.22% | -3.63% |
Feb. 08 | AstraZeneca targets 2024 growth as portfolio booms | RE |
Feb. 07 | Eli Lilly settles Minnesota lawsuit over insulin pricing | RE |
Sales 2023 | 43.07B 46.43B | Sales 2024 * | 45.74B 49.31B | Capitalization | 108B 117B |
---|---|---|---|---|---|
Net income 2023 | 5.4B 5.82B | Net income 2024 * | 7.76B 8.37B | EV / Sales 2023 | 2.79 x |
Net Debt 2023 | 7.79B 8.4B | Net Debt 2024 * | 2.09B 2.25B | EV / Sales 2024 * | 2.42 x |
P/E ratio 2023 |
20.8
x | P/E ratio 2024 * |
14.6
x | Employees | 91,573 |
Yield 2023 |
4.19% | Yield 2024 * |
4.4% | Free-Float | 87.77% |
Latest transcript on Sanofi
1 day | +0.83% | ||
1 week | -1.22% | ||
Current month | -7.35% | ||
1 month | -9.13% | ||
3 months | +0.49% | ||
6 months | -10.45% | ||
Current year | -3.63% |
Managers | Title | Age | Since |
---|---|---|---|
Paul Hudson
CEO | Chief Executive Officer | 56 | 19-08-31 |
Director of Finance/CFO | 58 | 18-09-30 | |
Nestle Frank
CTO | Chief Tech/Sci/R&D Officer | - | 16-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Serge Weinberg
BRD | Director/Board Member | 73 | 09-12-15 |
Patrick Kron
BRD | Director/Board Member | 70 | 14-04-30 |
Lise Kingo
BRD | Director/Board Member | 62 | 20-04-27 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
6.31% | 5 M€ | +4.56% | ||
3.66% | 123 M€ | -.--% | - | |
3.55% | 264 M€ | +13.50% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-02-09 | 86.5 | +0.83% | 1,366,254 |
24-02-08 | 85.79 | -1.83% | 1,299,894 |
24-02-07 | 87.39 | +0.18% | 1,121,528 |
24-02-06 | 87.23 | -0.19% | 1,194,411 |
24-02-05 | 87.4 | -0.19% | 1,285,472 |
Real-time Euronext Paris, February 09, 2024 at 11:37 am EST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.63% | 117 B $ | |
+26.97% | 666 B $ | |
+19.17% | 536 B $ | |
+0.01% | 377 B $ | |
+15.07% | 318 B $ | |
+12.33% | 307 B $ | |
-8.02% | 207 B $ | |
+4.05% | 206 B $ | |
-7.92% | 191 B $ | |
-4.27% | 156 B $ |